Skip to content
Disclosery

13F-HR/A filed by Kite Lake Capital Management (UK) LLP

Kite Lake Capital Management (UK) LLP filed this 13F-HR/A for the quarter ended 2019-12-31, filed 2020-03-10, with 3 holding rows worth $31,565,000.

Accession
0000919574-20-002265
Filer
CIK 1687444
Filed
2020-03-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, amendment of type restatement, 5 entries on the cover page, a total value of $31,565,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $31,565,000 with VALUE read as thousands by filing date, 13F file number 028-18700. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHINA BIOLOGIC PRODS HLDGS IG21515104COM207,382$24,135,000thousands by filing date
QIAGEN NVN72482123SHS NEW180,455$6,099,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/9999442,340$1,331,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-20-001374 superseded2020-02-14acceptance time not in the bulk data set
13F-HR/A 0000919574-20-002265this filing2020-03-10acceptance time not in the bulk data set